A Mississippi man has filed a federal lawsuit against Janssen Pharmaceuticals that alleges that the defendant’s negligence caused him to suffer from severe, permanent medical complications. Jim Dedeaux was prescribed Invokana by his physician, a diabetes medication manufactured by the defendant. He took it as prescribed, assuming from the information... Read more »

The makers of Farxiga, Bristol-Myers Squibb and AstraZeneca, are facing at least 18 product liability lawsuits filed in federal courts. These have now been centralized into a multidistrict litigation (MDL) pursuant to an order issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued on April 6, 2017. The... Read more »

A woman that developed ketoacidosis after taking the diabetes drug Invokana has filed a lawsuit against the drug’s manufacturers. Sheryl Desalis is claiming in her complaint that Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanabe Pharma failed to provide proper warnings about the risks of diabetic ketoacidosis associated with their... Read more »

The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »

A report recently published in the renowned JAMA Psychiatry journal indicates that children who are given antipsychotic drugs including Risperdal, Seroquel and Zyprexa may experience a greater likelihood of developing diabetes than those who have not been prescribed those medications to treat their mental health conditions. The study, conducted by doctors from... Read more »

Metabolic acidosis is a risk associated with Invokana that was recently highlighted in a report by the Institute for Safe Medical Practices (ISMP). Invokana is one of the drugs recently touted for its ability to manage type 2 diabetes, but potential side effects have raised concerns and led to a... Read more »

Anthony R. Allen has filed a lawsuit against Johnson & Johnson and Mitsubishi Tanabe Pharm Corp. He claims that the defendants’ prescription medication, Invokana, resulted in serious injuries that could have claimed his life. Allen is an Illinois resident who began using Invokana in December of 2014. The plaintiff’s Invokana... Read more »

A California woman has filed a product lability lawsuit against Janssen Pharmaceuticals and Johnson & Johnson, alleging that the defendants’ product, Invokana, caused serious complications. Jennifer Anzo filed the Invokana lawsuit late in October 2015 in the U.S. District Court for the Eastern District of California. She is demanding compensation... Read more »

Plaintiff Gene Schurman, a resident of Illinois, claims he suffered severe kidney damage after taking the diabetes drug Invokana under the direction of his doctor. He is now suing Janssen Pharmaceuticals, Johnson & Johnson and Mitsubishi Tanabe Pharma Corporation on claims of failure to warn, product liability, design defect, fraud,... Read more »

London-based AstraZeneca failed to obtain FDA approval for a proposed diabetes drug that combines two different medications, saxagliptin and dapagliflozin. In October 2015, the FDA issued a complete response letter to the pharmaceutical giant’s application. The agency requested additional clinical research on the proposed combination drug. AstraZeneca recently released statements... Read more »